Showing results (221-230 of 280) with videos related to
Sort By:
Pageof 28
American Journal of Hematology|October 6, 2025
Allogeneic Hematopoietic Stem Cell Transplantation in Adolescents and Young Adults With Acute Lymphoblastic Leukemia-A Retrospective, Dual-Center StudyOren Pasvolsky, Shai Shimony, Rima M Saliba, et al.Science Translational Medicine|November 3, 2017
A precision therapy against cancers driven by KIT/PDGFRA mutationsErica K Evans, Alexandra K Gardino, Joseph L Kim, et al.Blood|May 21, 2021
The clinical and functional effects of TERT variants in myelodysplastic syndromeChristopher R Reilly, Mikko Myllymäki, Robert Redd, et al.American Journal of Hematology|July 22, 2014
De novo acute myeloid leukemia with 20-29% blasts is less aggressive than acute myeloid leukemia with ≥30% blasts in older adults: a Bone Marrow Pathology Group studyRobert Paul Hasserjian, Federico Campigotto, Veronica Klepeis, et al.Nature Medicine|December 7, 2021
Efficacy and safety of avapritinib in advanced systemic mastocytosis: interim analysis of the phase 2 PATHFINDER trialJason Gotlib, Andreas Reiter, Deepti H Radia, et al.Blood Advances|October 6, 2021
Adding venetoclax to fludarabine/busulfan RIC transplant for high-risk MDS and AML is feasible, safe, and activeJacqueline S Garcia, Haesook T Kim, H Moses Murdock, et al.Science Translational Medicine|December 9, 2016
Individualized vaccination of AML patients in remission is associated with induction of antileukemia immunity and prolonged remissionsJacalyn Rosenblatt, Richard M Stone, Lynne Uhl, et al.Cancer Cell|June 5, 2003
PKC412 overcomes resistance to imatinib in a murine model of FIP1L1-PDGFRα-induced myeloproliferative diseaseJan Cools, Elizabeth H Stover, Christina L Boulton, et al.Blood Neoplasia|March 20, 2026
Comparative effectiveness of HMA with venetoclax vs intensive chemotherapy in AML with very high-risk cytogeneticsLuis E Aguirre, Jan Philipp Bewersdorf, Yiwen Liu, et al.Proceedings of the National Academy of Sciences of the United States of America|December 19, 2009
Functional screening identifies CRLF2 in precursor B-cell acute lymphoblastic leukemiaAkinori Yoda, Yuka Yoda, Sabina Chiaretti, et al.Pageof 28